Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
The American Journal of Psychiatry
|
May 17, 2011
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD
Cheryl L P Vigen, Wendy J Mack, Richard S E Keefe, et al.
Schizophrenia Research
|
April 2, 2019
Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial
Henry W Mahncke, Sarah-Jane Kim, Annika Rose, et al.
Biological Psychiatry
|
October 31, 2009
Genomewide association study of movement-related adverse antipsychotic effects
Karolina Aberg, Daniel E Adkins, József Bukszár, et al.
The Journal of Clinical Psychiatry
|
September 7, 2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
Stanley N Caroff, Vicki G Davis, Del D Miller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia
Joseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
The Journal of Clinical Psychiatry
|
December 7, 2007
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
Troy A Moore, Robert W Buchanan, Peter F Buckley, et al.
The Journal of Clinical Psychiatry
|
June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
Richard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Psychiatric Services (Washington, D.C.)
|
May 21, 2025
Prevalence of Past-Year Mental and Substance Use Disorders, 2021-2022
Heather Ringeisen, Mark Edlund, Heidi Guyer, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
The New England Journal of Medicine
|
October 13, 2006
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S Schneider, Pierre N Tariot, Karen S Dagerman, et al.
The American Journal of Psychiatry
|
May 17, 2011
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD
Cheryl L P Vigen, Wendy J Mack, Richard S E Keefe, et al.
Schizophrenia Research
|
April 2, 2019
Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial
Henry W Mahncke, Sarah-Jane Kim, Annika Rose, et al.
Biological Psychiatry
|
October 31, 2009
Genomewide association study of movement-related adverse antipsychotic effects
Karolina Aberg, Daniel E Adkins, József Bukszár, et al.
The Journal of Clinical Psychiatry
|
September 7, 2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
Stanley N Caroff, Vicki G Davis, Del D Miller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia
Joseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
The Journal of Clinical Psychiatry
|
December 7, 2007
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update
Troy A Moore, Robert W Buchanan, Peter F Buckley, et al.
The Journal of Clinical Psychiatry
|
June 13, 2012
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
Richard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Psychiatric Services (Washington, D.C.)
|
May 21, 2025
Prevalence of Past-Year Mental and Substance Use Disorders, 2021-2022
Heather Ringeisen, Mark Edlund, Heidi Guyer, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Page
of 14